Here are four things to know:
1. Under the planned deal, Rite Aid investors would own roughly 30 percent of the combined organization, which would comprise 319 health clinics and more than 4,300 pharmacies, Forbes reports.
2. Proponents of the sale argue the deal represents the best offer Rite Aid will receive for the remainder of its business as Amazon’s potential foray into the pharmacy space looms and rival organizations like Walgreens Boots Alliance and CVS Health explore mergers and acquisitions options to grow. In Rite Aid’s July 21 letter to shareholders, officials said they “do not expect any other bidders” for the company.
3. However, new analyses of the proposed deal suggest Rite Aid could operate as a standalone organization and may find a better deal elsewhere, according to the report.
4. Rite Aid on Aug. 6 issued a worse than projected fiscal 2019 forecast. The company forecasted a net loss in 2019 of “between $125 million and $170 million, updated from the previously disclosed range of between $40 million and $95 million.”
To access the report, click here.
More articles on transactions and valuations:
8 recent healthcare partnerships and transactions
Hackensack Meridian, Carrier Clinic to merge: 3 notes
19 recent healthcare partnerships and transactions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
